Evidence map›Paper›PMID 41924271›Full record

ArticleFrontiers in immunology2026

Cellular sensor DAP5 decodes

Yao Lu, Jun Xiao, Jiale Wang, Zihan Meng, Guangyue Fan, Jian Zheng, Minghang Yu, Xi Wang, Long Li

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yao Lu *Tianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology, Department of Immunology, Tianjin Medical University, Tianjin, China.
Jun Xiao *State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin Institute of Immunology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Jiale Wang *Tianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology, Department of Immunology, Tianjin Medical University, Tianjin, China.
Zihan MengTianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology, Department of Immunology, Tianjin Medical University, Tianjin, China.
Guangyue FanTianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology, Department of Immunology, Tianjin Medical University, Tianjin, China.
Jian ZhengTianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology, Department of Immunology, Tianjin Medical University, Tianjin, China.
Minghang YuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Xi WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Long LiTianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology, Department of Immunology, Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Viral infection induces host cells to enter a state of "virus-induced senescence (VIS)", which provides a stable cellular environment for viral replication. However, it is unclear about the molecular mechanism of this process. Here, we identified cellular protein DAP5 and its N-terminal fragment DAP5 Methods: Upon SARS-CoV-2 infection, cellular apoptosis and senescence levels were assessed. This led to the identification of DAP5 as a pivotal proteolytic substrate that links viral protease activity to host cell fate determination. The specific cleavage site on DAP5 targeted by the non-structural protein 5 (NSP5) encoded by SARS-CoV-2 was mapped using Western Blot and Fluorescence Resonance Energy Transfer (FRET) analysis. The functional role of the resulting N-terminal fragment DAP5 Results: Viral infection-activated caspase 3 cleaves DAP5, which contributed to positive feedback loops, reinforcing apoptotic process. NSP5 interrupted the apoptotic process by NSP5-specific cleavage of DAP5 that led to the production of the N-terminal fragment DAP5 Conclusions: Our findings clarify the mechanism of SARS-CoV-2 induced VIS and establish a model of host cells inhibiting VIS through protein degradation and limiting viral replication, which provides a basis for subsequent immunological studies of emergent pathogenic microbial infection.

Indexed as

Apoptosis Regulatory ProteinsCellular SenescenceCOVID-19SARS-CoV-2Viral Nonstructural ProteinsAnimalsApoptosisHEK293 CellsHost-Pathogen InteractionsHumansProteolysisUbiquitinationVirus ReplicationApoptosis Regulatory ProteinsViral Nonstructural ProteinsDAP5NSP5TRIM7viral replicationvirus-induced senescence

Identifiers

PMID41924271
PMCPMC13036145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.